Enterprise Lithuania becomes a partner of Venture Valuation/Biotechgate

Media release

Enterprise Lithuania becomes a partner of Venture Valuation/Biotechgate

Zurich / Vilnius, Jan 2021 Venture Valuation/Biotechgate announce a cooperation with Enterprise Lithuania, trade promotion governmental agency.

As per the agreement of the two parties, the Lithuanian Biotech Database has been set-up, a regional portal integrated with Biotechgate Business Development Database. Access to the portal is free for all users, and its main purpose is to promote Lithuanian life science industry globally.  The database provides a profile of all listed companies to foster international collaborations and provide an overview of the key strength of the Lithuanian Life Science industry.

Additionally, Venture Valuation will be involved in promoting Life Science Baltics, one of Enterprise Lithuania’s flagship events targeted to a global audience. The event will take place on 22-23 September 2021 and over 1,800 world-class biotechnology, pharmaceutical and medical devices experts are expected to attend from more than 40 different countries. 

“International investors and global pharma and biotech companies are more and more interested in Baltic countries, and we have been actively looking for partners in the region for a while. Enterprise Lithuania is a perfect match for us because they have a special team working exclusively for the life science industry, and they are very close to the startup community.” – Dr. Patrik Frei, CEO and Founder of Venture Valuation/Biotechgate

“Lithuania’s life sciences companies and research teams are ready to help ambitious businesses to take their next big leap. By partnering with Venture Valuation/Biotechgate we hope to spread the message about growing Lithuania’s life sciences environment combined with excellent rankings for our entrepreneurial environment, as well as our leadership in technology, international scientific achievements, up to date infrastructure, highly qualified professionals and science graduates” – Daina Klepone, Managing Director at Enterprise Lithuania

Lithuanian Biotech Database: www.lithuanianbiotech.com

Venture Valuation AG – www.venturevaluation.com

Venture Valuation specializes in independent, third-party assessment and valuation of biotechnology, pharma and med-tech companies. Services are provided in the form of independent Valuation Reports to entrepreneurs (seed to pre-IPO) and investors. With offices in Switzerland, Ireland, UK, Canada, USA and Asia, Venture Valuation has an experienced team of scientists and business professionals with expertise in finance, biotechnology, pharmaceutical and regulatory.

Enterprise Lithuania – www.enterpriselithuania.com

Enterprise Lithuania was established by the Lithuanian Ministry of Economy and Innovation in 2009 to promote entrepreneurship, support business development and export of Lithuanian companies, with a focus on SMEs. The agency provides training, consultancy, market analysis, and business-partner search services, and is a dedicated facilitator of the startup ecosystem. Furthermore, Enterprise Lithuania serves as an entry-point and a communication channel for foreign organizations and institutions who wish to explore business opportunities in the country. 

Download the press release

Would you like to be notified about new interviews, reports and other valuable content published by Venture Valuation?